Amoxicillinum, Acidum clavulanicum
Medicinal product name | Betaklav 400 mg/57 mg/5 ml powder for oral suspension |
---|---|
Pharmaceutical form | Powder for oral suspension |
Strength | 400 mg/57 mg/5 ml |
Information from the MAH on shortages | No information on expected shortages |
Legal status | Reimbursed medicines reference product |
Prescription (Pr.)
Package leaflet | 01-02-2024 |
Summary of product characteristics | 01-02-2024 |
ATC code | J01CR02 – Antibacterials for systemic use |
Information for Marketing authorisation holders | View |
Medicinal products (4)
Availability of medicinal product | Wholesalers | Package size, content | Primary packaging | Maximum admissible pharmacy price (€ incl. VAT) | Product No. | Labelling |
---|---|---|---|---|---|---|
Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N1 (30 ml) |
HDPE bottle | 15-0236-01 |
Labelling text Feb 1, 2024 Labelling text Feb 1, 2024 |
|
Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N1 (60 ml) |
HDPE bottle | 15-0236-02 |
Labelling text Feb 1, 2024 Labelling text Feb 1, 2024 |
|
Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N1 (70 ml) |
HDPE bottle |
€ 4.89 * |
15-0236-03 |
Labelling text Feb 1, 2024 Labelling text Feb 1, 2024 |
Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N1 (100 ml) |
HDPE bottle | 15-0236-04 |
Labelling text Feb 1, 2024 Labelling text Feb 1, 2024 |
Registration information
Marketing authorisation No. | 15-0236 |
---|---|
Date of authorisation | Oct 5, 2015 |
Marketing authorisation holder, country | KRKA, d.d., Novo mesto, Slovenia |